- (1) Each RMHI shall have a staff member designated by the Chief Executive Officer or designee to be the Patient Rights Advocate (PRA).
- (2) The PRA’s job plan shall include the duties imposed by these rules.
- (3) The PRA shall work cooperatively with other RMHI staff members, shall be an objective advocate for patient rights, and shall effectively present the patient’s views and wishes in the procedures.
- (4) The PRA shall work with RMHI staff members in conducting both initial and continuing education on the requirements of these rules.
- (5) The PRA shall maintain a compliance monitoring file on each patient receiving psychotropic medication, physical treatment, and/or release of information under Rules 0940-01-02-.07, 0940-01-02-.08, 0940-01-02-.09, 0940-01-02-.10, or 0940-01-02-.11.
- (6) The PRA shall compile a summary of actions taken at least annually and shall submit a report to the RMHI Governing Body Quality Committee for its review.
- (7) The PRA’s duties in implementing these rules shall take priority over other duties as a general patient rights advocate and over other duties they may be assigned.
Authority: T.C.A. §§ 33-1-302 through 33-1-305, 33-3-104, 33-6-107, and 33-6-1006. Administrative History: New rules filed December 22, 2025; effective March 22, 2026.